Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEGI for hypertensive intracerebral hemorrhage
ChiCTR1800016620Phase 4Not yet recruiting
- Sponsor
- Fourth Medical Center of PLA General Hospital
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in intracerebral hemorrhage (ICH) and intraparenchymal hematoma (IPH) comparing CEGI injection with Placebo (2 arms). Primary endpoint: Glasgow Outcome Scale - Extended (GOS-E). Planned start Jun 2018; status: not yet recruiting.
02
Drugs
cattle encephalon glycoside and ignotin
03
Conditions
intracerebral hemorrhage (ICH)intraparenchymal hematoma (IPH)
Beyond the preview
Go deeper on ChiCTR1800016620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016620.